Show simple item record

dc.contributor.authorFranculino, Kleber Alves da Silva [UNESP]
dc.contributor.authorGomes, Rogério [UNESP]
dc.date.accessioned2018-12-11T17:32:45Z
dc.date.available2018-12-11T17:32:45Z
dc.date.issued2017-01-01
dc.identifier.citationEspacios, v. 38, n. 26, 2017.
dc.identifier.issn0798-1015
dc.identifier.urihttp://hdl.handle.net/11449/178928
dc.description.abstractThis study aims to evaluate how public policies adopted by Brazil and India in past decades have influenced the development of the pharmaceutical industry in these countries. The industry performance is measured by international trade indicators, from 1995 to 2011, to capture the effects of the adoption of the TRIPS Agreement on the productive structure of medicines. Two hypothesis are assumed: international trade flows may express aspects of the industry competitiveness; and the success of these public policies implicates in increased competitiveness. The results indicate that the continuity of the policies is crucial to explain the differences of industry competitiveness in both countries.en
dc.language.isoeng
dc.relation.ispartofEspacios
dc.sourceScopus
dc.subjectBrazil
dc.subjectCompetitiveness
dc.subjectIndia
dc.subjectPharmaceutical industry
dc.subjectPublic policies
dc.titlePublic policies and competitiveness in the pharmaceutical industry: The case of Brazil and Indiaen
dc.typeArtigo
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.description.affiliationUniversidade Estadual Paulista (FCL/Ar)
dc.description.affiliationDepartment of Economic's UNESP
dc.description.affiliationUnespUniversidade Estadual Paulista (FCL/Ar)
dc.description.affiliationUnespDepartment of Economic's UNESP
dc.rights.accessRightsAcesso restrito
dc.identifier.scopus2-s2.0-85020183279
dc.relation.ispartofsjr0,144
Localize o texto completo

Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record